[Report] Global Catheters Market Research, Trends, Analysis TOC

INTRODUCTION
- STUDY GOALS AND OBJECTIVES
- REASONS FOR DOING THIS STUDY
- CONTRIBUTIONS TO THE STUDY AND FOR WHOM
- SCOPE AND FORMAT
- METHODOLOGY
- ABOUT THE AUTHOR
- INFORMATION SOURCES
- DISCLAIMER
SUMMARY
- SUMMARY
- Summary Table:
- PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2012 ($ BILLIONS/%)
- Summary Figure 1:
- GLOBAL CATHETER SEGMENT SHARES, 2007 (%)
- Summary Figure 2:
- PROJECTED GLOBAL CATHETER SHARES BY SEGMENT, 2012 (%)
GLOBAL CATHETER MARKET
- GLOBAL CATHETER MARKET (CONTINUED)
- CATHETER APPLICATIONS
- TYPES OF CATHETERS
  - CARDIOVASCULAR CATHETERS
- Table 1 INDICATIONS FOR CARDIAC CATHETERIZATION
  - Types of Cardiac Catheters
  - Diagnostic Catheters
  - Therapeutic Catheters
  - Angiography Catheters
  - EP Catheters
  - Percutaneous Coronary Intervention (PCI) Catheters
- Table 2 PTCA PROCEDURES
  - Rapid Exchange PTCA Balloon Catheters
  - Over-the-Wire PTCA Catheters
    - Guiding Catheter
- UROLOGY CATHETERS
  - Urology Catheters (Continued)
  - Types of Urology Catheters
    - Intermittent Catheterization
    - Indwelling Catheterization
    - Suprapubic Catheterization
    - Male External Condom Catheters
- NEUROVASCULAR CATHETERS
- INTRAVENOUS (IV) CATHETERS
  - Types of IV Catheters
    - Single Lumen Catheters
    - Multi-Lumen Catheter
    - Peripheral Vein Catheter
    - Central Venous Catheter
    - Peripherally Inserted Central Catheters
- Table 3 COMPLICATIONS DUE TO IV CATHETERS
  - SPECIALTY CATHETERS
    - Types of Specialty Catheters
      - Thermodilution Catheters
      - Suction Catheters
      - Oximetry Catheters
  - END-USER PREFERENCES
    - SIZE OF CATHETER
    - MATERIAL USED
    - COATING
    - COST
    - DURATION OF CATHETER IN THE BODY
    - INFECTION
  - DEMOGRAPHIC IMPACT
  - ZERO DIVIDE
- Table 4 U.S. RATE OF CARDIOVASCULAR PROCEDURES, 2004*
  - EUROPEAN DEMOGRAPHICS
- Table 5 EUROPEAN CORONARY PROCEDURES, 2004 (PER MILLION POPULATION)
  - ECONOMIC DEMOGRAPHICS
- Table 6 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 1960-2003
- Table 7 PER CAPITA HEALTHCARE EXPENDITURE BY COUNTRY, 1960-2003 ($)
CATHETER MATERIALS
- KEY CHARACTERISTICS OF CATHETER MATERIALS
- Table 8 CHARACTERISTICS OF CATHETER MATERIALS
  - CATHETER MATERIALS
    - LATEX
    - SILICONE
    - POLYURETHANE
    - POLYVINYL CHLORIDE (PVC)
    - TEFLON (FLUOROPOLYMER)
    - POLYETHYLENE
  - CATHETER COATINGS
    - SILICONE ELASTOMER
    - HYDROPHILIC COATING
    - ANTIMICROBIAL COATING
    - SILVER COATING
  - ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS
- Table 9 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS
- Table 9 (CONTINUED)
- Table 10 CATHETER PRODUCTS BY MATERIAL AND COATING TYPE
- Table 10 (CONTINUED)
ANALYSIS OF THE GLOBAL CATHETER MARKET
- Figure 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET
  - KEY MARKET CHALLENGES
    - LACK OF CLINICAL DATA DETERS ACCEPTANCE OF NEW PRODUCTS BY MEDICAL STAFF
    - GROUP PURCHASING IS INDUCING DOWNWARD PRICE PRESSURES
    - DEVELOPMENTS IN PHARMACOLOGICAL THERAPEUTICS ARE THREATENING USE OF CATHETERS
    - SOME SEGMENTS ARE HIGHLY CONCENTRATED, IMPACTING THE OVERALL GROWTH OF THE CATHETER MARKET
    - CATHETER REUSE IS IMPACTING SALES OF DISPOSABLE CATHETERS
  - KEY MARKET DRIVERS
    - INCREASE IN PROCEDURES HAS LED TO INCREASED DEMAND FOR CATHETERS
    - INCREASED DEMAND FOR DISPOSABLE CATHETERS DUE TO RISK OF INFECTION AND AIDS
    - NEW TECHNOLOGIES IN CATHETERS HAVE INCREASED CATHETER USE
    - INCREASE IN MINIMALLY INVASIVE PROCEDURES REQUIRING CATHETERS HAS INCREASED SALES
    - ADVANCES IN IMAGING TECHNOLOGY HAS LED TO NEW APPLICATIONS REQUIRING THE USE OF CATHETERS
  - KEY MARKET RESTRAINTS
    - PRICE EROSIONS DUE TO FIERCE COMPETITION ARE SHRINKING REVENUES
    - LONG FDA APPROVAL TIMES ARE RESULTING IN DELAYED LAUNCHES OF NEW PRODUCTS
    - REIMBURSEMENT ISSUES HAVE IMPACTED THE USE OF TECHNOLOGICALLY ADVANCED CATHETERS
    - PHYSICIANS IN THE BUSINESS LONG TERM TEND TO BE RELUCTANT TO ACCEPT NEW DEVICE TECHNOLOGIES
  - GLOBAL CATHETER MARKET ANALYSIS
    - REVENUES, SHARES, AND PROJECTIONS BY SEGMENT
- Table 11 PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2012 ($ BILLIONS)
- Figure 2 PROJECTED GLOBAL CATHETER MARKET, 2005-2012 ($ BILLIONS)
- Table 12 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, THROUGH 2012 (%)
- Figure 3 GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2007 (%)
- Figure 4 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2012 (%)
  - REVENUES, SHARES, AND PROJECTIONS BY REGION
- Table 13 PROJECTED GLOBAL CATHETER MARKET BY REGION, THROUGH 2012 ($ BILLIONS)
- Figure 5 PROJECTED GLOBAL CATHETER MARKET BY REGION, 2005-2012 ($ BILLIONS)
- Table 14 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2007 AND 2012 (%)
- Figure 6 GLOBAL CATHETER MARKET SHARES BY REGION, 2007 (%)
- Figure 7 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2012 (%)
  - U.S. Catheter Market
  - European Catheter Market
  - Rest of the World Catheter Market
- REPROCESSED CATHETERS
  - REPROCESSED CATHETERS (CONTINUED)
- COMPETITIVE STRUCTURE
  - TYPES OF COMPETITION
  - TIERS OF COMPETITION
  - MERGERS AND ACQUISITIONS
- Table 15 KEY MERGERS AND ACQUISITIONS WITHIN THE CATHETER MARKET ($)
- Table 15 (CONTINUED)
  - END-USER GROUPS
  - DISTRIBUTION STRUCTURE
  - PURCHASE STRUCTURE
  - COMPETITIVE FACTORS
    - Regulatory Environment
    - Pricing
    - Catheter Properties
    - Branding
  - SWOT ANALYSIS OF THE GLOBAL CATHETER MARKET
- Figure 8 SWOT ANALYSIS OF THE GLOBAL CATHETER MARKET
  - STRENGTHS
  - WEAKNESSES
  - OPPORTUNITIES
  - THREATS
CARDIOVASCULAR CATHETERS
- KEY MARKET CHALLENGES
  - CONTROVERSY REGARDING THE USE OF DRUG ELUTING STENTS (DES) IS AFFECTING CATHETER USE
  - PHARMACOLOGICAL APPROACHES IS THREATENING CATHETER DEMAND
  - LACK OF CLINICAL DATA IS HINDERING ACCEPTANCE OF NEWER CATHETERS BY PHYSICIANS
- KEY MARKET DRIVERS
  - INCREASE IN THE INCIDENCE OF CV DISEASES IS INCREASING THE NUMBER OF PROCEDURES
  - POPULARITY OF ANGIOPLASTY AND STENTS OVER BYPASS SURGERY IS LEADING TO AN INCREASE IN THE USE OF CARDIAC CATHETERS
  - ANGIOGRAPHY, A NEAR FOOLPROOF METHOD IN THE DETECTION OF CARDIAC DISEASE, IS DRIVING THE INCREASE IN THE NUMBER OF DIAGNOSTIC PROCEDURES
  - INTERVENTIONAL CARDIAC PROCEDURES ARE MORE EFFECTIVE THAN DRUG-BASED THERAPIES
- KEY MARKET RESTRAINTS
  - CONSTANT PRICE EROSION IS LEADING TO DECREASED REVENUES
  - DECREASE IN RESTENOSIS IS IMPACTING STENT PROCEDURES
  - CATHETER USAGE IS RESTRAINED DUE TO LOW REIMBURSEMENT RATES
  - CARDIOVASCULAR CATHETER MARKET ANALYSIS
  - REVENUES AND PROJECTIONS BY TYPE OF CATHETER
- Table 16 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)
- Figure 9 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, 2005-2012 ($ BILLIONS)
  - MARKET SHARES AND PROJECTIONS BY TYPE OF CATHETER
- Table 17 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY TYPE, 2007 AND 2012 (%)
  - MARKET SHARES AND PROJECTIONS BY REGION
- Figure 10 GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2007 (%)
- Figure 11 PROJECTED GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2012 (%)
  - MARKET SHARES BY COMPANY
- Table 18 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 12 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)
  - CARDIOVASCULAR CATHETER PRODUCTS BY COMPANY
- Table 19 ANGIOGRAPHY CATHETER PRODUCTS BY COMPANY
- Table 20 EP CATHETER PRODUCTS BY COMPANY
- Table 20 (CONTINUED)
- Table 21 PTCA CATHETER PRODUCTS BY COMPANY
- Table 21 (CONTINUED)
- Table 22 GUIDING CATHETER PRODUCTS BY COMPANY
  - COMPETITIVE STRUCTURE
UROLOGY CATHETER MARKET
- KEY MARKET CHALLENGES
  - USE OF LONG-TERM CATHETERS IS THREATENING THE GROWTH OF DISPOSABLE CATHETERS
  - USE OF CATHETERSHAS DECLINED DUE TO AN INCREASE IN THE NUMBER OF URINARY TRACT INFECTIONS (UTI)
  - SOME PHYSICIANS ARE NOT READY TO ACCEPT NEW PRODUCTS DUE TO A LACK OF CLINICAL DATA
- KEY MARKET DRIVERS
  - INCREASE IN UROLOGY PROCEDURES IS LEADING TO INCREASED CATHETER USE
  - CATHETERS WITH ANTIMICROBIAL COATINGS ARE INCREASING CONFIDENCE IN THE USE OF CATHETERS
  - SOME PRODUCTS CAN BE USED BY PATIENTS THEMSELVES, INCREASING PATIENT ADOPTION
- KEY MARKET RESTRAINTS
  - LENGHTY FDA APPROVAL TIMES HAVE LED TO DELAYS IN THE LAUNCH OF EFFECTIVE ANTIMICROBIAL CATHETERS
  - OCCURRENCES OF UTI IS DISCOURAGING CATHETER USAGE
- UROLGY CATHETER MARKET ANALYSIS
  - REVENUES AND PROJECTIONS BY TYPE OF CATHETER
- Table 23 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)
- Figure 13 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, 2005-2012 ($ MILLIONS)
  - MARKET SHARES AND PROJECTIONS BY TYPE OF CATHETER
- Table 24 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2007 AND 2012 (%)
- Figure 14 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2007 (%)
- Figure 15 GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2012 (%)
  - MARKET SHARES BY COMPANY
- Table 25 GLOBAL UROLOGY CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 16 UROLOGY CATHETER MARKET SHARES BY COMPANY, 2007 (%)
  - UROLOGY CATHETER PRODUCTS BY COMPANY
- Table 26 UROLOGY CATHETER PRODUCTS BY COMPANY
- COMPETITIVE STRUCTURE
NEUROVASCULAR CATHETER MARKET
- KEY MARKET CHALLENGES
  - COST OF SPECIALIZED MICROCATHETERS IMPACTS THEIR ADOPTION
- KEY MARKET DRIVERS
  - ADVANCES IN IMAGING TECHNOLOGIES ARE CREATING NEW AREAS OF DIAGNOSIS AND TREATMENT
  - STENTING AND ANEURYSM TREATMENTS ARE INCREASING CATHETER USE
  - NEW CATHETER TECHNOLOGIES ARE IMPROVING PROCEDURESAND INCREASING DEMAND
  - MARKET POTENTIAL EXISTS IN UNMET TREATMENT OPTIONS
- KEY MARKET RESTRAINTS
  - INCREASED AVAILABILITY OF PHARMACOLOGICAL TREATMENT OPTIONS IS INHIBITING NEURO CATHETER USE
  - SHORTAGE OF PROFESSIONALS QUALIFIED TO PERFORM INVASIVE NEUROLOGICAL PROCEDURES IS IMPACTING NEURO CATHETER SALES
  - MANY PATIENTS DIE BEFORE RECEIVING TREATMENT
- NEUROVASCULAR CATHETER MARKET ANALYSIS
  - REVENUES AND PROJECTIONS BY SEGMENT
- Table 27 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, THROUGH 2012 ($ BILLIONS)
- Figure 17 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, 2005-2012 ($ BILLIONS)
  - MARKET SHARES BY COMPANY
- Table 28 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 18 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)
  - NEUROVASCULAR CATHETER PRODUCTS BY COMPANY
- Table 29 NEUROVASCULAR CATHETER PRODUCTS BY COMPANY
  - COMPETITIVE STRUCTURE
INTRAVENOUS CATHETER MARKET
- KEY MARKET CHALLENGES
  - LACK OF CLINICAL DATA CHALLENGES ADOPTION OF NEW IV CATHETERS
  - MANUFACTURERS FACE PRICE EROSION AND FIERCE COMPETITION
- KEY MARKET DRIVERS
  - STRICT CATHETER REPLACEMENT RULES ARE INCREASING SALES
  - IV CATHETERS WITH ANTIMICROBIAL COATINGS HAVE IMPROVED THEIR MARKETABILITY
  - INCREASE IN APPLICATIONS AND INTRODUCTION OF NEW TECHNOLOGY IS BOOSTING IV CATHETER SALES
- KEY MARKET RESTRAINTS
  - CONSTANT PRICE EROSION IS LEADING REVENUE LOSSES
  - REIMBURSEMENT ISSUES REDUCE THE USE OF HIGH-END IV CATHETERS
- INTRAVENOUS CATHETER MARKET ANALYSIS
  - REVENUES AND PROJECTIONS BY CATHETER TYPE
- Table 30 PROJECTED GLOBAL IV CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)
- Figure 19 PROJECTED GLOBAL INTRAVENOUS CATHETER MARKET, 2005-2012 ($ BILLIONS)
  - MARKET SHARES AND PROJECTIONS BY CATHETER TYPE
- Table 31 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2007 (%)
- Figure 20 GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2007 (%)
- Figure 21 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2012 (%)
  - MARKET SHARES BY COMPANY
- Table 32 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 22 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2007 (%)
  - IV CATHETER PRODUCTS BY COMPANY
    - Peripheral Intravenous Catheter Products by Company
- Table 33 PERIPHERAL INTRAVENOUS CATHETER PRODUCTS BY COMPANY
  - Central Venous Catheter Products by Company
- Table 34 CENTRAL VENOUS CATHETER PRODUCTS BY COMPANY
  - PICC Products by Company
- Table 35 PICC PRODUCTS BY COMPANY
  - COMPETITIVE STRUCTURE
SPECIALTY CATHETERS
- KEY MARKET CHALLENGES
  - LACK OF CLINICAL DATA IN SUPPORT OF EFFICACY
- KEY MARKET DRIVERS
  - DEMAND FOR ENHANCED MONITORING DEVICES IS LEADING TO MORE SALES
  - SPECIALTY CATHETER' S EFFECTIVENESS IS FUELING INTEREST IN MEDICAL STAFF AND PROMOTING USE
- KEY MARKET RESTRAINTS
  - HIGH PRICE OF CATHETERS INHIBITS SALES
  - HIGH COST OF SPECIALTY CATHETERS RENDERS THEM UNAFFORDABLE FOR DEVELOPING COUNTRIES AND REDUCES REVENUES
- SPECIALTY CATHETER MARKET ANALYSIS
  - REVENUES AND PROJECTIONS BY CATHETER TYPE
- Table 36 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)
- Figure 23 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, 2005-2012 ($ BILLIONS)
  - MARKET SHARES AND PROJECTIONS BY CATHETER TYPE
- Table 37 PROJECTED GLOBAL SPECIALTY CATHETER MARKET SHARES BY TYPE, 2007 AND 2012 (%)
- Figure 24 GLOBAL SPECIALTY CATHETER SHARES BY TYPE, 2007 (%)
- Figure 25 PROJECTED GLOBAL SPECIALTY CATHETER SHARES BY TYPE, 2012 (%)
  - MARKET SHARES BY COMPANY
- Table 38 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 26 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2007 (%)
  - SPECIALTY PRODUCTS BY COMPANY
- Table 39 SPECIALTY CATHETER PRODUCT APPLICATIONS BY COMPANY
  - COMPETITIVE STRUCTURE
GOVERNMENT REGULATIONS AND ISSUES
- CATHETER MARKET REGULATIONS
  - CLASS I MEDICAL DEVICES
  - CLASS II
  - CLASS III
- Table 40 CATHETER TYPES AND CLASS
- Table 40 (CONTINUED)
  - RECENT 510(K) APPROVALS BY FDA
- Table 41 U.S. FDA 510(K) APPROVALS OF CATHETERS, 2006-2007
- Table 41 (CONTINUED)
- Table 41 (CONTINUED)
  - RECENT FDA APPROVALS (2005 TO 2007)
- Table 42 RECENT FDA APPROVALS
  - IBI THERAPY DUAL 8 ABLATION CATHETER AND IBI 1500T6 (USA) GENERATOR
  - NAVISTAR AND CELSIUS THERMOCOOL IRRIGATED DEFLECTABLE DIAGNOSTIC/ABLATION CATHETER
  - COAXIA NEUROFLO CATHETER
- FDA RECALLS
  - MISLABELING
  - NON-STERILE CONDITIONS
  - MANUFACTURING DEFECTS
  - MALFUNCTIONS
- Table 43 CATHETER RECALLS IN THE PAST YEAR
- Table 43 (CONTINUED)
- Table 43 (CONTINUED)
  - FDA APPROVAL PROCESS
    - PREMARKET NOTIFICATION 510(K)
      - Premarket Notification 510(k) (Continued)
    - PREMARKET APPROVAL
    - INVESTIGATIONAL DEVICE EXEMPTION (IDE)
    - ESTABLISHMENT REGISTRATION FORM
    - MEDICAL DEVICE LISTING
    - QUALITY SYSTEM (QS) REGULATION
    - LABELING
    - MEDICAL DEVICE REPORTING
  - HEALTHCARE STANDARDS
    - EUROPEAN STANDARDS
      - The Active Implantable Medical Device Directive (AIMD) [90/385/EEC]
      - The Medical Device Directive (MDD) [93/42/EEC]
      - The In Vitro Medical Devices Directive (IVD) [98/79/EC]
    - ISO (INTERNATIONAL ORGANIZATION FOR STANDARDS)
- Table 44 CATHETER ISO NUMBERS
  - DIFFERENCES IN EUROPEAN AND U.S. REGULATIONS
COMPANY PROFILES
- ABBOTT LABORATORIES
- Table 45 ABBOTT LABORATORIES' CATHETER PRODUCTS
- Table 45 (CONTINUED)
  - ARROW INTERNATIONAL
- Table 46 ARROW INTERNATIONAL CATHETER PRODUCTS
  - ASTRA TECH AB
- Table 47 ASTRA TECH CATHETER PRODUCTS
  - B BRAUN MELSUNGEN AG
- Table 48 B BRAUN CATHETER PRODUCTS
  - BECTON, DICKINSON & CO.
- Table 49 BD CATHETER PRODUCTS
  - BOSTON SCIENTIFIC
- Table 50 BOSTON SCIENTIFIC CATHETER PRODUCTS
  - CARDINAL HEALTH
- Table 51 CARDINAL HEALTH CATHETER PRODUCTS
  - COLOPLAST GROUP
- Table 52 COLOPLAST CATHETER PRODUCTS
  - COOK MEDICAL
- Table 53 COOK MEDICAL CATHETER PRODUCTS
  - CR BARD
- Table 54 CR BARD CATHETER PRODUCTS
- Table 54 (CONTINUED)
  - EDWARDS LIFESCIENCES
- Table 55 EDWARDS LIFESCIENCES CATHETER PRODUCTS
  - HOSPIRA, INC.
- Table 56 HOSPIRA CATHETER PRODUCTS
  - IRVINE BIOMEDICAL, INC.
- Table 57 IRVINE BIOMEDICAL CATHETER PRODUCTS
  - JOHNSON & JOHNSON
- Table 58 JOHNSON & JOHNSON CATHETER PRODUCTS
  - MEDTRONIC, INC.
- Table 59 MEDTRONIC CATHETER PRODUCTS
  - ROCHESTER MEDICAL
- Table 60 ROCHESTER MEDICAL CATHETER PRODUCTS
  - SMITHS MEDICAL
- Table 61 SMITHS MEDICAL CATHETER PRODUCTS
- Table 61 (CONTINUED)
  - ST. JUDE MEDICAL
- Table 62 ST. JUDE MEDICAL CATHETER PRODUCTS
  - TERUMO MEDICAL CORP.
- Table 63 TERUMO CORP. CATHETER PRODUCTS
- Table 63 (CONTINUED)
- Table 64 REVENUES OF KEY CATHETER MANUFACTURERS, 2005 AND 2006 ($ BILLIONS)
- Table 64 (CONTINUED)
PATENT ANALYSIS
- PATENT ANALYSIS BY SEGMENT
- Table 65 CATHETER PATENT SHARES BY SEGMENT, 2002 TO MAY 2007 (%)
- Figure 27 CATHETER PATENT SHARES BY SEGMENT, 2002 TO MAY 2007 (%)
  - CARDIOVASCULAR CATHETER PATENTS
- Table 66 CARDIOVASCULAR CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007
- Figure 28 CARDIOVASCULAR PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
  - UROLOGY CATHETER PATENTS
- Table 67 UROLOGY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Figure 29 UROLOGY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
  - IV CATHETER PATENTS
- Table 68 IV CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Figure 30 IV CATHETER PATENT ACTIVITY, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
  - SPECIALTY CATHETER PATENTS
- Table 69 SPECIALTY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Figure 31 SPECIALTY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
  - CATHETER PATENT ACTIVITY BY ASSIGNEE
- Table 70 CATHETER PATENT ACTIVITY BY ASSIGNEE, 2002 TO MAY 2007 (NUMBER OF PATENTS)
- Figure 32 CATHETER PATENT SHARES BY ASSIGNEE, 2002 TO MAY 2007 (%)
- Figure 32 (CONTINUED)
- Table 71 U.S. CATHETER PATENT NUMBERS BY ASSIGNEE, 1995 TO MAY 2007
- Table 71 (CONTINUED)
  - CATHETER PATENT ACTIVITY BY COUNTRY
- Table 72 CATHETER PATENT ACTIVITY BY COUNTRY, 2002 TO MAY 2007
- Figure 33 CATHETER PATENT SHARES BY COUNTRY, 2002 TO MAY 2007 (%)
  - CATHETER PATENT ACTIVITY BY YEAR
- Table 73 PATENT FILINGS PER YEAR, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Figure 34 PATENT FILINGS PER YEAR, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
  - U.S. PATENT ABSTRACTS
    - OCCLUSION BALLOON CATHETER WITH LONGITUDINALLY EXPANDABLE BALLOON
    - CATHETER-ADVANCEMENT ACTUATED NEEDLE RETRACTION SYSTEM
    - STEERABLE CATHETER
    - MULTI-LUMEN CATHETER HAVING A SOFT TIP
    - CATHETER FOR ELECTROPHYSIOLOGY
    - CATHETER WITH A DISPOSABLE BALLOON
    - CURVED ABLATION CATHETER FOR ENHANCED MANEUVERING
    - EXTERNAL URINARY CATHETER
    - MICROCATHETER FOR RETRIEVING EMBOLIC COILS
    - INTRAVENOUS CATHETER
    - HIGH TORQUE BALLOON CATHETER
    - SURGICAL CATHETER WITH AUXILIARY LUMEN
    - CONCLUSIONS OF THE PATENT ANALYSIS
APPENDIX
- Table 74 CATHETER DEFINITIONS
- Table 74 (CONTINUED)
- Table 75 KEY INDUSTRY WEBSITES
- Table 76 KEY REGULATORY AND INFORMATION WEBSITES
  - CURRENCY CONVERSIONS
LIST OF TABLES
- Summary Table:
- PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2012 ($ BILLIONS/%)
- Table 1 INDICATIONS FOR CARDIAC CATHETERIZATION
- Table 2 PTCA PROCEDURES
- Table 3 COMPLICATIONS DUE TO IV CATHETERS
- Table 4 U.S. RATE OF CARDIOVASCULAR PROCEDURES, 2004*
- Table 5 EUROPEAN CORONARY PROCEDURES, 2004 (PER MILLION POPULATION)
- Table 6 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 1960-2003
- Table 7 PER CAPITA HEALTHCARE EXPENDITURE BY COUNTRY, 1960-2003 ($)
- Table 8 CHARACTERISTICS OF CATHETER MATERIALS
- Table 9 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS
- Table 10 CATHETER PRODUCTS BY MATERIAL AND COATING TYPE
- Table 11 PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2012 ($ BILLIONS)
- Table 12 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, THROUGH 2012 (%)
- Table 13 PROJECTED GLOBAL CATHETER MARKET BY REGION, THROUGH 2012 ($ BILLIONS)
- Table 14 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2007 AND 2012 (%)
- Table 15 KEY MERGERS AND ACQUISITIONS WITHIN THE CATHETER MARKET ($)
- Table 16 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)
- Table 17 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY TYPE, 2007 AND 2012 (%)
- Table 18 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Table 19 ANGIOGRAPHY CATHETER PRODUCTS BY COMPANY
- Table 20 EP CATHETER PRODUCTS BY COMPANY
- Table 21 PTCA CATHETER PRODUCTS BY COMPANY
- Table 22 GUIDING CATHETER PRODUCTS BY COMPANY
- Table 23 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)
- Table 24 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2007 AND 2012 (%)
- Table 25 GLOBAL UROLOGY CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Table 26 UROLOGY CATHETER PRODUCTS BY COMPANY
- Table 27 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, THROUGH 2012 ($ BILLIONS)
- Table 28 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Table 29 NEUROVASCULAR CATHETER PRODUCTS BY COMPANY
- Table 30 PROJECTED GLOBAL IV CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)
- Table 31 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2007 (%)
- Table 32 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Table 33 PERIPHERAL INTRAVENOUS CATHETER PRODUCTS BY COMPANY
- Table 34 CENTRAL VENOUS CATHETER PRODUCTS BY COMPANY
- Table 35 PICC PRODUCTS BY COMPANY
- Table 36 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, THROUGH 2012 ($ BILLIONS)
- Table 37 PROJECTED GLOBAL SPECIALTY CATHETER MARKET SHARES BY TYPE, 2007 AND 2012 (%)
- Table 38 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Table 39 SPECIALTY CATHETER PRODUCT APPLICATIONS BY COMPANY
- Table 40 CATHETER TYPES AND CLASS
- Table 41 U.S. FDA 510(K) APPROVALS OF CATHETERS, 2006-2007
- Table 42 RECENT FDA APPROVALS
- Table 43 CATHETER RECALLS IN THE PAST YEAR
- Table 44 CATHETER ISO NUMBERS
- Table 45 ABBOTT LABORATORIES' CATHETER PRODUCTS
- Table 46 ARROW INTERNATIONAL CATHETER PRODUCTS
- Table 47 ASTRA TECH CATHETER PRODUCTS
- Table 48 B BRAUN CATHETER PRODUCTS
- Table 49 BD CATHETER PRODUCTS
- Table 50 BOSTON SCIENTIFIC CATHETER PRODUCTS
- Table 51 CARDINAL HEALTH CATHETER PRODUCTS
- Table 52 COLOPLAST CATHETER PRODUCTS
- Table 53 COOK MEDICAL CATHETER PRODUCTS
- Table 54 CR BARD CATHETER PRODUCTS
- Table 55 EDWARDS LIFESCIENCES CATHETER PRODUCTS
- Table 56 HOSPIRA CATHETER PRODUCTS
- Table 57 IRVINE BIOMEDICAL CATHETER PRODUCTS
- Table 58 JOHNSON & JOHNSON CATHETER PRODUCTS
- Table 59 MEDTRONIC CATHETER PRODUCTS
- Table 60 ROCHESTER MEDICAL CATHETER PRODUCTS
- Table 61 SMITHS MEDICAL CATHETER PRODUCTS
- Table 62 ST. JUDE MEDICAL CATHETER PRODUCTS
- Table 63 TERUMO CORP. CATHETER PRODUCTS
- Table 64 REVENUES OF KEY CATHETER MANUFACTURERS, 2005 AND 2006 ($ BILLIONS)
- Table 65 CATHETER PATENT SHARES BY SEGMENT, 2002 TO MAY 2007 (%)
- Table 66 CARDIOVASCULAR CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007
- Table 67 UROLOGY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Table 68 IV CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Table 69 SPECIALTY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Table 70 CATHETER PATENT ACTIVITY BY ASSIGNEE, 2002 TO MAY 2007 (NUMBER OF PATENTS)
- Table 71 U.S. CATHETER PATENT NUMBERS BY ASSIGNEE, 1995 TO MAY 2007
- Table 72 CATHETER PATENT ACTIVITY BY COUNTRY, 2002 TO MAY 2007
- Table 73 PATENT FILINGS PER YEAR, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Table 74 CATHETER DEFINITIONS
- Table 75 KEY INDUSTRY WEBSITES
- Table 76 KEY REGULATORY AND INFORMATION WEBSITES
LIST OF FIGURES
- Summary Figure 1:
- GLOBAL CATHETER SEGMENT SHARES, 2007 (%)
- Summary Figure 2:
- PROJECTED GLOBAL CATHETER SHARES BY SEGMENT, 2012 (%)
- Figure 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET
- Figure 2 PROJECTED GLOBAL CATHETER MARKET, 2005-2012 ($ BILLIONS)
- Figure 3 GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2007 (%)
- Figure 4 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2012 (%)
- Figure 5 PROJECTED GLOBAL CATHETER MARKET BY REGION, 2005-2012 ($ BILLIONS)
- Figure 6 GLOBAL CATHETER MARKET SHARES BY REGION, 2007 (%)
- Figure 7 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2012 (%)
- Figure 8 SWOT ANALYSIS OF THE GLOBAL CATHETER MARKET
- Figure 9 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, 2005-2012 ($ BILLIONS)
- Figure 10 GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2007 (%)
- Figure 11 PROJECTED GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2012 (%)
- Figure 12 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 13 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, 2005-2012 ($ MILLIONS)
- Figure 14 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2007 (%)
- Figure 15 GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2012 (%)
- Figure 16 UROLOGY CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 17 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, 2005-2012 ($ BILLIONS)
- Figure 18 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 19 PROJECTED GLOBAL INTRAVENOUS CATHETER MARKET, 2005-2012 ($ BILLIONS)
- Figure 20 GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2007 (%)
- Figure 21 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2012 (%)
- Figure 22 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 23 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, 2005-2012 ($ BILLIONS)
- Figure 24 GLOBAL SPECIALTY CATHETER SHARES BY TYPE, 2007 (%)
- Figure 25 PROJECTED GLOBAL SPECIALTY CATHETER SHARES BY TYPE, 2012 (%)
- Figure 26 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2007 (%)
- Figure 27 CATHETER PATENT SHARES BY SEGMENT, 2002 TO MAY 2007 (%)
- Figure 28 CARDIOVASCULAR PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Figure 29 UROLOGY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Figure 30 IV CATHETER PATENT ACTIVITY, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Figure 31 SPECIALTY CATHETER PATENT ACTIVITY BY TYPE, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)
- Figure 32 CATHETER PATENT SHARES BY ASSIGNEE, 2002 TO MAY 2007 (%)
- Figure 33 CATHETER PATENT SHARES BY COUNTRY, 2002 TO MAY 2007 (%)
- Figure 34 PATENT FILINGS PER YEAR, 2002 TO MAY 2007 (NUMBER OF PATENTS FILED)

The Global Catheters Market

Table of Contents